Stockreport

Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]

Benitec Biopharma Inc.  (BNTC) 
US:NASDAQ Investor Relations: benitec.com/for-investors/investor-faqs
PDF -Data Safety Monitoring Board Review for First Subject Completed After Day 28 Study Visit- -Second Subject Scheduled to Receive BB-301 in February 2024- -23 Subject [Read more]